Skip to main content

Table 1 Patient’s characteristics (n = 57)

From: The impact of homocysteine, B12, and D vitamins levels on functional neurocognitive performance in HIV-positive subjects

Variable

Age (ys)

51.0 ± 9.8

Gender, n(%)

 Male

50 (87.7)

 Female

7 (12.3)

BMI (Kg/m2)

25.7 ± 3.6

Level of instruction (ys)

10.8 ± 3.1

History of HIV infection (ys)

11.1 ± 7.5

Risk factors, n(%)

 MSM

22 (38.6)

 Ex-IDU

11 (19.1)

 Heterosexual

24 (42.1)

Therapy, n(%)

 NRTI

53 (93.0)

 NNRTI

20 (35.1)

 IP

20 (35.1)

 INSTIs

20 (35.1)

HCV, n(%)

9 (15.8)

HBV, n(%)

6 (10.5)

Glycaemia (mg/dl)

98.8 ± 48.8

Total cholesterol (mg/dl)

198.2 ± 44.2

HDL cholesterol (mg/dl)

51.8 ± 16.9

LDL cholesterol (mg/dl)

113.4 ± 40.0

Triglycerides (mg/dl)

164.8 ± 99.0

Creatinine (mg/dl)

1.0 ± 0.9

Albumin (g/dl)

4.6 ± 1.0

25-0H D Vitamin (ng/ml)

26.8 ± 9.3

Homocysteine (μmol/l)

15.1 ± 6.3

B12 Vitamin (ng/ml)

378.5 ± 151.8

Folate (ng/ml)

9.8 ± 13.7

  1. MSM men sex with men; IDU injection drug users; NRTI nucleoside reverse transcriptase inhibitor; NNRTI non-nucleoside reverse transcriptase inhibitor; IP Protease Inhibitors; INSTIs Integrase strand transfer inhibitors